Does Black Diamond Therapeutics Inc (BDTX) Have What it Takes to be in Your Portfolio Wednesday?

Black Diamond Therapeutics Inc (BDTX) is around the top of the Biotechnology industry according to InvestorsObserver. BDTX received an overall rating of 63, which means that it scores higher than 63 percent of all stocks. Black Diamond Therapeutics Inc also achieved a score of 86 in the Biotechnology industry, putting it above 86 percent of Biotechnology stocks. Biotechnology is ranked 72 out of the 148 industries.

BDTX has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on BDTX!

See Full BDTX Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Black Diamond Therapeutics Inc Stock Today?

Black Diamond Therapeutics Inc (BDTX) stock is trading at $2.70 as of 12:59 PM on Wednesday, Oct 11, a loss of -$0.04, or -1.28% from the previous closing price of $2.73. The stock has traded between $2.67 and $2.97 so far today. Volume today is 389,104 compared to average volume of 483,720. Click Here to get the full Stock Report for Black Diamond Therapeutics Inc stock.